User menu

A peptide encoded by human gene MAGE-3 and presented by HLA-B44 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3.

Bibliographic reference Herman, Jean ; van der Bruggen, Pierre ; Luescher, I F ; Mandruzzato, S ; Romero, P. ; et. al. A peptide encoded by human gene MAGE-3 and presented by HLA-B44 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3.. In: Immunogenetics, Vol. 43, no. 6, p. 377-83 (1996)
Permanent URL
  1. Atherton, E., Logan, C. J., and Sheppard, R. C. Peptide synthesis. Part 2. Procedures for solid phase synthesis using Nα-fluorenyl-methysoxycarbamylamino-acid on polymide supports. Synthesis of substance P and of acyl carrier protein 65–74 decapeptide.J Chem Soc Lond Perkin Trans 1: 538, 1981
  2. Boon, T., Cerottini, J.-C., Van den Eynde, B., van der Bruggen, P., and Van Pel, A. Tumor antigens recognized by T lymphocytes.Annu Rev Immunol 12: 337–365, 1994
  3. Brasseur, F., Marchand, M., Vanwijck, R., Hérin, M., Lethé, B., Chomez, P., and Boon, T. Human gene MAGE-1, which codes for a tumor rejection antigen, is expressed by some breast tumors.Int J Cancer 52: 839–841, 1992
  4. Brasseur, F., Rimoldi, D., Liénard, D., Letbé, B., Carrel, S., Arienti, F., Suter, L., Vanwijck, R., Bourlond, A., Humblet, Y., Vacca, A., Conese, M., Lahaye, T., Degiovanni, G., Deraemaecker, R., Beauduin, M., Sastre, X., Salamon, E., Dréno, B., Jäger, E., Knuth, A., Chevreau, C., Suciu, S., Lachapelle, M., Pouillart, P., Parmiani, G., Lejeune, F., Cerottini, J.-C., Boon, T., and Marchand, M. Expression of MAGE genes in primary and metastatic cutaneous melanoma.Int J Cancer 63: 375–380, 1995
  5. Brichard, V. G., Herman, J., Van Pel, A., Wildmann, C., Gaugler, B., Wölfel, T., Boon, T., and Lethé, B. A tyrosinase nonapeptide presented by HLA-B44 is recognized on a human melanoma by autologous cytolytic T lymphocytes.Eur J Immunol 26: 224–230, 1996
  6. Burrows, S. R., Misko, I. S., Sculley, T. B., Schmidt, C., and Moss, D. J. An Epstein-Barr virus-specific cytotoxic T-cell epitope present on A- and B-type transformants.J J Virol 64: 3974–3976, 1990
  7. Buseyne, F., McChesney, M., Porrot, F., Kovarik, S., Guy, B., and Rivière, Y. Gag-specific cytotoxic T lymphocytes from human immunodeficiency virus type 1-infected individuals: gag epitopes are clustered in three regions of the p24gag protein.J Virol 67: 694–702, 1993
  8. Celis, E., Tsai, V., Crimi, C., DeMars, R., Wentworth, P. A., Chesnut, R. W., Grey, H. M., Sette, A., and Serra, H. M. Induction of antitumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes.Proc Natl Acad Sci USA 91: 2105–2109, 1994
  9. Coulie, P. G., Lehmann, F., Lethé, B., Herman, J., Lurquin, C., Andrawiss, M., and Boon, T. A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma.Proc Natl Acad Sci USA 92: 7976–7980, 1995
  10. De Plaen, E., Arden, K., Traversari, C., Gaforio, J. J., Szikora, J.-P, De Smet, C., Brasseur, R., van der Bruggen, P., Lethé, B., Lurquin, C., Brasseur, R., Chomez, P., De Backer, O., Cavenee, W., and Boon, T. Structure, chromosomal localization and expression of twelve genes of theMAGE family.Immunogenetics 40: 360–369, 1994
  11. Del Guercio, M.-E., Sidney, J., Hermanson, G., Perez, C., Grey, H. M., Kubo, R. T., and Sette, A. Binding of a peptide antigen to multiple HLA alleles allows definition of an A2-like supertype.J Immunol 154: 685–693, 1995
  12. DiBrino, M., Parker, K. C., Margulies, D. H., Shiloach, J., Turner, R. V., Biddison, W. E., and Coligan, J. E. Identification of the peptide binding motif for HLA-B44, one of the most common HLA-B alleles in the Caucasian population.Biochemistry 34: 10130–10138, 1995
  13. Espevik, T. and Nissen-Meyer, J. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes.J Immunol Methods 95: 99–105, 1986
  14. Fleischhauer, K., Kernan, N. A., O'Reilly, R. J., Dupont, B., and Yang, S. Y. Bone marrow-allograft rejection by T lymphocytes recognizing a single amino acid difference in HLA-B44.N Engl J Med 323. 1818–1822, 1990
  15. Fleischhauer, K., Kernan, N. A., Dupont, B., and Yang, S. Y. The two major subtypes of HLA-B44 differ for a single amino acid in codon 156.Tissue Antigens 37: 133–137, 1991
  16. Fleischhauer, K., Avila, D., Vilbois, F., Traversari, C., Bordignon, C., and Wallny, H. Characterization of natural peptide ligands for HLA-B*4402 and HLA-B*4403: implications for peptide involvement in allorecognition of a single amino acid change in the HLAB44 heavy chain.Tissue Antigens 44: 311–7317, 1994
  17. Gaugler, B., Van den Eynde, B., van der Bruggen, P., Romero, P., Gaforio, J. J., De Plaen, E., Lethé, B., Brasseur, F., and Boon, T. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes.J Exp Med 179: 921–930, 1994
  18. Gluzman, Y. SV40-transformed simian cells support the replication of early SV40 mutants.Cell 23: 175–182, 1981
  19. Imanishi, T., Akaza, T., Kimura, A., Tokunaga, K., and Gojobori, T. Allele and haplotype frequencies for HLA and complement loci in various ethnic groups. In K. Tsuji, M. Aizawa, and T. Sasazuki (eds.):HLA 1991, Vol 1, XIth International Histocompatibility Workshop and Conference, Oxford University Press, Oxford, 1991
  20. Keever, C. A., Leong, N., Cunningham, I., Copelan, E. A., Avalos, B. R., Klein, J., Kapoor, N., Adams, P. W., Orosz, C. G., Tutschka, P. J., and Baxter-Lowe, L. A. HLA-B44-directed cytotoxic T cells associated with acute graft-versus-host disease following unrelated bone marrow transplantation.Bone Marrow Transplant 14: 137–145, 1994
  21. Khanna, R., Burrows, S. R., Kurilla, M. G., Jacob, C. A., Misko, I. S., Sculley, T. B., Kieff, E., and Moss, D. J. Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development.J Exp Med 176: 169–176, 1992
  22. Kita, H., Moriyama, T., Kaneko, T., Harase, I., Nomura, M., Miura, H., Nakamura, I., Yazaki, Y., and Imawari, M. HLA-B44-restricted cytotoxic T lymphocytes recognizing an epitope on hepatitis C virus nucleocapsid protein.Hepatology 18: 1039–1044, 1993
  23. Lee T. D., Distribution of HLA Antigens, The HLA System (1990) ISBN:9781461280187 p.141-178, 10.1007/978-1-4612-3454-8_6
  24. Lehmann, F., Marchand, M., Hainaut, P., Pouillart, P., Sastre, X., Ikeda, H., Boon, T., and Coulie, P. G. Differences in the antigens recognized by cytolytic T cells on two successive metastases of a melanoma patient are consistent with immune selection.Eur J Immunol 25: 340–347, 1995
  25. Mikamo, S. A novel method for the purification of sheep red cell rosetting lymphocytes.J Immunol Methods 107: 189–196, 1988
  26. Muscatelli, F., Walker, A. P., De Plaen, E., Stafford, A. N., and Monaco, A. P. Isolation and characterisation of a new MAGE gene family in the Xp21.3 region.Proc Natl Acad Sci USA, 92: 4987–4991, 1995
  27. Patard, J.-J., Brasseur, F., Gil-Diez, S., Radvanyi, F., Marchand, M., François, P., Abi Aad, A., Van Cangh, P., Abbou, C. C., Chopin, D., and Boon, T. Expression of MAGE genes in transitional-cell carcinomas of the urinary bladder.Int J Cancer 64: 60–64, 1995
  28. Petersdorf, E. W., Setoda, T., Smith, A. G., and Hansen, J. A. Analysis of HLA-13*44 alleles encoded on extended HLA haplotypes by direct automated sequencing.Tissue Antigens 44: 211–216, 1994
  29. Romani, N., Gruner, S., Brang, D., Kämpgen, E., Lenz, A., Trockenbacher, B., Konwalinka, G., Fritsch, P O., Steinman, R. M., and Schuler, G. Proliferating dendritic cell progenitors in human blood.J Exp Med 180: 83–93, 1994
  30. Russo, V., Traversari, C., Verrecchia, A., Mottolese, M., Natali, P. G., and Bordignon, C.: Expression of the MAGE gene family in primary and metastatic human breast cancer: implications for tumor antigen-specific immunotherapy.Int J Cancer 64: 216–221, 1995
  31. Sallusto, F. and Lanzavecchia, A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α.J Exp Med 179: 1109–1118, 1994
  32. Seed, B. and Aruffo, A. Molecular cloning of the CD2 antigen, the T-cell erythrocyte receptor, by a rapid immunoselection procedure.Proc Natl Acad Sci USA 84: 3365–3369, 1987
  33. Sidney, J., del Guercio, M.-F., Southwood, S., Engelhard, V. H., Appella, E., Rammensee, H.-G., Falk, K., Rötzschke, O., Takiguchi, M., Kubo, R. T., Grey, H. M., and Sette, A. Several HLA alleles share overlapping peptide specificities.J Immunol 154: 247–259, 1995
  34. Storkus, W. J., Howell, D. N., Salter, R. D., Dawson, J. R., and Cresswell, P. NK susceptibility varies inversely with target cell class I HLA antigen expression.J Immunol 138: 1657–1659, 1987
  35. Traversari, C., van der Bruggen, P., Luescher, I. F., Lurquin, C., Chomez, P., Van Pel, A., De Plaen, E., Amar-Costesec, A., and Boon, T. A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-Al by cytolytic T lymphocytes directed against tumor antigen MZ2-E.J Exp Med 176: 1453–1457, 1992
  36. Van der Bruggen, P., Bastin, J., Gajewski, T., Coulie, P. G., Boël, P., De Smet, C., Traversari, C., Townsend, A., and Boon, T. A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3.Eur J Immunol 24: 3038–3043, 1994
  37. Van der Bruggen, P., Traversari, C., Chomez, P., Lurquin, C., De Plaen, E., Van den Eynde, B., Knuth, A., and Boon, T. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma.Science 254: 1643–1647, 1991
  38. Weynants, P., Lethé, B., Brasseur, F., Marchand, M., and Boon, T. Expression of MAGE genes by non-small-cell lung carcinomas.Int J Cancer 56: 826–829, 1994
  39. Yao, Z., Keller, E., Scholz, S., McNicholas, A., Volgger, A., and Albert, A. Identification of two major HLA-1344 subtypes and a novel B44 sequence (B*4404).Hum Immunol 42: 54–60, 1995a
  40. Yao, Z., Lattermann, A., Volgger, A., McNicholas, A., Mueller-Eckhardt, G., and Albert, E. A newHLA-B44 subtype,B*4406, differing in exon 2.Immunogenetics 41: 387, 1995b
  41. Yao, Z., Volgger, A., Scholz, S., Bönisch, J., and Albert, E. D. Nucleotide sequence of a novel HLA-B44 subtype (B*4405).Immunogenetics 40: 310, 1994